Christopher Raymond
Stock Analyst at Raymond James
(2.08)
# 3,265
Out of 5,108 analysts
877
Total ratings
43.2%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Christopher Raymond
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Downgraded: Hold | n/a | $1.11 | - | 2 | Nov 4, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $870 → $1,020 | $902.90 | +12.97% | 115 | Oct 30, 2026 | |
| AMGN Amgen | Reiterated: Hold | n/a | $460.28 | - | 79 | Sep 24, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $50 | $20.89 | +139.35% | 9 | Sep 23, 2026 | |
| BHVN Biohaven | Reiterated: Buy | n/a | $13.90 | - | 24 | Sep 10, 2026 | |
| ALMS Alumis | Reiterated: Buy | n/a | $5.85 | - | 3 | Sep 2, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $39 | $34.08 | +14.44% | 1 | Aug 14, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $3.28 | - | 1 | Aug 10, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $19 → $15 | $2.99 | +401.67% | 42 | Aug 7, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $105 | $56.12 | +87.10% | 87 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.87 | - | 3 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $14.85 | +169.36% | 1 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $29.58 | +102.84% | 20 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.91 | +760.59% | 2 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.09 | +217.85% | 6 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 → $123 | $67.22 | +82.98% | 5 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 → $29 | $8.51 | n/a | 11 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $2.36 | n/a | 14 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $533 → $401 | $542.50 | n/a | 26 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.61 | n/a | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $15.57 | n/a | 58 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $4 | $8.85 | n/a | 6 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $84.18 | n/a | 5 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $220 → $227 | $288.24 | n/a | 84 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $0.0601 | n/a | 21 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $307 → $315 | $243.93 | n/a | 91 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $56 | $28.27 | n/a | 11 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $7.63 | n/a | 19 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.000001 | n/a | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $8 | $1.15 | n/a | 24 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.4255 | n/a | 22 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $600 | $894.77 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $38.80 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $22 | $48.87 | n/a | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.02 | n/a | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 | $1.30 | n/a | 5 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $37.54 | n/a | 1 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $4.01 | n/a | 6 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 → $30 | $6.18 | n/a | 5 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $1.45 | n/a | 20 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $45.71 | n/a | 12 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.60 | n/a | 4 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.13 | n/a | 6 | Aug 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $42 → $101 | - | n/a | 2 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0008 | n/a | 6 | Mar 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3 → $6 | $2.13 | n/a | 3 | Feb 29, 2012 |
Aardvark Therapeutics
Nov 4, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.11
Upside: -
Regeneron Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $870 → $1,020
Current: $902.90
Upside: +12.97%
Amgen
Sep 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $460.28
Upside: -
Tyra Biosciences
Sep 23, 2026
Reiterated: Buy
Price Target: $50
Current: $20.89
Upside: +139.35%
Biohaven
Sep 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.90
Upside: -
Alumis
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.85
Upside: -
SpyGlass Pharma
Aug 14, 2026
Initiated Coverage: Buy
Price Target: $39
Current: $34.08
Upside: +14.44%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.28
Upside: -
Ardelyx
Aug 7, 2026
Reiterated: Buy
Price Target: $19 → $15
Current: $2.99
Upside: +401.67%
BioMarin Pharmaceutical
Aug 7, 2026
Reiterated: Buy
Price Target: $105
Current: $56.12
Upside: +87.10%
Jun 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.87
Upside: -
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $14.85
Upside: +169.36%
Jan 26, 2026
Reiterated: Buy
Price Target: $60
Current: $29.58
Upside: +102.84%
Jan 13, 2026
Reiterated: Buy
Price Target: $25
Current: $2.91
Upside: +760.59%
Nov 25, 2025
Reiterated: Buy
Price Target: $13
Current: $4.09
Upside: +217.85%
Nov 14, 2025
Reiterated: Buy
Price Target: $142 → $123
Current: $67.22
Upside: +82.98%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $26 → $29
Current: $8.51
Upside: n/a
Sep 16, 2025
Reiterated: Buy
Price Target: $23
Current: $2.36
Upside: n/a
Sep 2, 2025
Initiated Coverage: Hold
Price Target: $533 → $401
Current: $542.50
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: $13
Current: $3.61
Upside: n/a
Feb 14, 2025
Reiterated: Buy
Price Target: $140
Current: $15.57
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $4
Current: $8.85
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $42
Current: $84.18
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $220 → $227
Current: $288.24
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $75
Current: $0.0601
Upside: n/a
Oct 30, 2024
Reiterated: Buy
Price Target: $307 → $315
Current: $243.93
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $56
Current: $28.27
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $20
Current: $7.63
Upside: n/a
Sep 16, 2024
Rated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: $21 → $8
Current: $1.15
Upside: n/a
Oct 25, 2023
Reiterated: Buy
Price Target: $4
Current: $0.4255
Upside: n/a
Oct 25, 2023
Reiterated: Buy
Price Target: $600
Current: $894.77
Upside: n/a
Oct 25, 2023
Reiterated: Buy
Price Target: $58
Current: $38.80
Upside: n/a
Jul 24, 2023
Rated: Hold
Price Target: $22
Current: $48.87
Upside: n/a
Apr 25, 2023
Reiterated: Buy
Price Target: $14
Current: $1.02
Upside: n/a
Nov 22, 2022
Reiterated: Hold
Price Target: $28
Current: $1.30
Upside: n/a
Jul 25, 2022
Initiated Coverage: Buy
Price Target: $28
Current: $37.54
Upside: n/a
May 23, 2022
Reiterated: Buy
Price Target: $3
Current: $4.01
Upside: n/a
May 18, 2022
Reiterated: Hold
Price Target: $75 → $30
Current: $6.18
Upside: n/a
May 11, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $1.45
Upside: n/a
Apr 13, 2021
Reiterated: Buy
Price Target: $8
Current: $45.71
Upside: n/a
Mar 27, 2020
Reiterated: Buy
Price Target: n/a
Current: $7.60
Upside: n/a
Aug 7, 2017
Rated: Hold
Price Target: n/a
Current: $2.13
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $42 → $101
Current: -
Upside: n/a
Mar 19, 2013
Reiterated: Hold
Price Target: n/a
Current: $0.0008
Upside: n/a
Feb 29, 2012
Upgraded: Buy
Price Target: $3 → $6
Current: $2.13
Upside: n/a